Diagnostic fiberoptic bronchoscopy. Unspecified bacterial pneumonia
Conditions
Interventions
Intervention 1: Intervention group: Transtracheal block, in which lidocaine is injected through the cricothyroid space using a 20G needle. Intervention 2: Intervention group: Deep inhalation nasal lid
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age are candidates for diagnostic fiberoptic bronchoscopy.
Exclusion criteria
Exclusion criteria: Lidocaine sensivity Cardiopulmonary failure Pregnancy Incorporation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of coughs recorded by an independent observer. Timepoint: During bronchoscopy and in recovery afterwards. Method of measurement: Questionnaire and observation by an observer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of sedation medication used. Timepoint: during bronchoscopy. Method of measurement: CC measured by the individual.;Occurrence of local side effects (burning, superficial bleeding, emphysema, seizures, etc.). Timepoint: During bronchoscopy and recovery. Method of measurement: Quantitative and Qualitative Questionnaire.;Overall patient satisfaction on a scale of 10. Timepoint: in PACU ward. Method of measurement: Quantitative and Qualitative Questionnaire.;Patient discomfort based on a visual-numeric scale of 0–10. Timepoint: PACU ward. Method of measurement: visual-numeric scale of 0–10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMoein Daneshmand
Shahid Beheshti University of Medical Sciences
Outcome results
None listed